FDA Final Guidance Advises on ANDA Labeling Updates for Reference Drug Changes

Two significant changes in the FDA’s final guidance on updating ANDA labeling are details on how to obtain information on changes to reference listed drug (RLD) labeling and how to submit revised ANDA labeling.
Source: Drug Industry Daily